- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 96.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 77.04M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.18M |
| Capex | Q1 2026 · Mar 31, 2025 | $3.78M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $43.18M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $34.43M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $317.81M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $235.33M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $186.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $529.31M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $480.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.02B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $960.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.65B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.55B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.28 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $33.31M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $46.18M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $15.94M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $19.44M |
| Net Income | Q1 2026 · Mar 31, 2026 | $24.69M |
| Net Income | Q1 2026 · Mar 31, 2025 | $7.89M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $80.01M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $47.69M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $177.56M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $167.08M |
| Revenue | Q1 2026 · Mar 31, 2026 | $298.99M |
| Revenue | Q1 2026 · Mar 31, 2025 | $282.7M |